BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 20135697)

  • 1. siRNA applications in nanomedicine.
    Tokatlian T; Segura T
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(3):305-15. PubMed ID: 20135697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies for in vivo delivery of siRNAs: recent progress.
    Higuchi Y; Kawakami S; Hashida M
    BioDrugs; 2010 Jun; 24(3):195-205. PubMed ID: 20462284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harnessing RNAi-based nanomedicines for therapeutic gene silencing in B-cell malignancies.
    Weinstein S; Toker IA; Emmanuel R; Ramishetti S; Hazan-Halevy I; Rosenblum D; Goldsmith M; Abraham A; Benjamini O; Bairey O; Raanani P; Nagler A; Lieberman J; Peer D
    Proc Natl Acad Sci U S A; 2016 Jan; 113(1):E16-22. PubMed ID: 26699502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanomedicine based approaches for the delivery of siRNA in cancer.
    Ozpolat B; Sood AK; Lopez-Berestein G
    J Intern Med; 2010 Jan; 267(1):44-53. PubMed ID: 20059643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges.
    Gomes-da-Silva LC; Fonseca NA; Moura V; Pedroso de Lima MC; Simões S; Moreira JN
    Acc Chem Res; 2012 Jul; 45(7):1163-71. PubMed ID: 22568781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical and structural modifications of RNAi therapeutics.
    Ku SH; Jo SD; Lee YK; Kim K; Kim SH
    Adv Drug Deliv Rev; 2016 Sep; 104():16-28. PubMed ID: 26549145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrophobization and bioconjugation for enhanced siRNA delivery and targeting.
    De Paula D; Bentley MV; Mahato RI
    RNA; 2007 Apr; 13(4):431-56. PubMed ID: 17329355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid and Polymer-Based Nanoparticle siRNA Delivery Systems for Cancer Therapy.
    Mainini F; Eccles MR
    Molecules; 2020 Jun; 25(11):. PubMed ID: 32532030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted delivery systems of small interfering RNA by systemic administration.
    Kawakami S; Hashida M
    Drug Metab Pharmacokinet; 2007 Jun; 22(3):142-51. PubMed ID: 17603214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung.
    Günther M; Lipka J; Malek A; Gutsch D; Kreyling W; Aigner A
    Eur J Pharm Biopharm; 2011 Apr; 77(3):438-49. PubMed ID: 21093588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioengineered nanoparticles for siRNA delivery.
    Kozielski KL; Tzeng SY; Green JJ
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2013; 5(5):449-68. PubMed ID: 23821336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonviral in vivo delivery of therapeutic small interfering RNAs.
    Aigner A
    Curr Opin Mol Ther; 2007 Aug; 9(4):345-52. PubMed ID: 17694447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient and targeted delivery of siRNA in vivo.
    Shim MS; Kwon YJ
    FEBS J; 2010 Dec; 277(23):4814-27. PubMed ID: 21078116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemistry and formulations for siRNA therapeutics.
    Gallas A; Alexander C; Davies MC; Puri S; Allen S
    Chem Soc Rev; 2013 Oct; 42(20):7983-97. PubMed ID: 23857524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interfering cancer with polymeric siRNA nanomedicines.
    Tiram G; Scomparin A; Ofek P; Satchi-Fainaro R
    J Biomed Nanotechnol; 2014 Jan; 10(1):50-66. PubMed ID: 24724498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivering siRNA with Dendrimers: In Vivo Applications.
    Leiro V; Santos SD; Pego AP
    Curr Gene Ther; 2017; 17(2):105-119. PubMed ID: 28494741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
    Varshosaz J; Farzan M
    World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Budding Alliance of Nanotechnology in RNA Interference Therapeutics.
    Kumawat A; Dapse P; Kumar N; Mishra DK; Maheshwari R; Bhattacharya P; Tekade RK
    Curr Pharm Des; 2018; 24(23):2632-2643. PubMed ID: 30084328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of nanocarriers for the delivery of small interfering RNA.
    Kesharwani P; Gajbhiye V; Jain NK
    Biomaterials; 2012 Oct; 33(29):7138-50. PubMed ID: 22796160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in siRNA delivery for cancer therapy using smart nanocarriers.
    Zhang P; An K; Duan X; Xu H; Li F; Xu F
    Drug Discov Today; 2018 Apr; 23(4):900-911. PubMed ID: 29373841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.